Volume 20, Number 4—April 2014
Spread of Virulent Group A Streptococcus Type emm59 from Montana to Wyoming, USA
Full-genome sequencing showed that a recently emerged and hypervirulent clone of group A Streptococcus type emm59 active in Canada and parts of the United States has now caused severe invasive infections in rural northeastern Wyoming. Phylogenetic analysis of genome data indicated that the strain was likely introduced from Montana.
Strains of group A Streptococcus (GAS) type emm59 historically have not been commonly associated with invasive infections. However, a striking increase in the frequency and severity of invasive infections caused by type emm59 strains recently occurred in Canada (1).
Four of the authors (M.L.M., P.L.F., R.N., and M.M.) cared for 4 patients whose cases were temporally clustered and who had severe invasive infections caused by GAS in northeastern Wyoming, USA. Of the 4 case-patients, 2 were directly linked. Case-patient 4 contracted invasive infection from a close-contact family member (case-patient 2). Case-patient 3 was a physician who had cared for case-patients 1 and 2. These infections occurred in an area close to where a cluster of 6 invasive emm59 infections occurred in Montana in 2010 (2). This fact led us to determine whether genetically related emm59 strains were responsible. Full-genome sequencing confirmed this hypothesis (Figure).
A 19-year-old otherwise healthy man had generalized body aches, mild confusion, and cough and was treated symptomatically as an outpatient. The next day, he was found unconscious at his home. In the emergency department, he had hypoxemia, metabolic acidosis, renal failure, leukopenia with 34% bands, and severe unilateral pneumonia. Coagulopathy and sepsis-induced cardiomyopathy with global hypokinesia and reduced ejection fraction developed. He was discharged after a complicated hospital stay. GAS isolated from his throat and blood were discarded but a convalescent-phase serum sample was strongly reactive in a GAS-specific ELISA.
On day 13 after disease onset in case-patient 1, a 78-year-old man with multiple medical problems was hospitalized with cellulitis of the left upper arm. An intravenous line had been inserted into the arm during a cardiac-related hospital admission 4 days earlier. Blood cultures grew GAS. Intravenous vancomycin was administered, and he was discharged and followed up as an outpatient. The following morning, he was found obtunded at home. He had hypoxemia, hypotension, new acute renal failure, and new full-thickness skin necrosis with bullae, mottling, and ecchymoses of the affected arm. He was hospitalized, given broad-spectrum antimicrobial drugs, and provided fluid and pressor support. Imaging studies showed evidence of necrotizing fasciitis. The affected arm was amputated and necrotizing fasciitis was confirmed. He died within 48 hours after hospitalization.
Nineteen days after case-patient 1 was treated and 2 days after case-patient 2 died, generalized chills, profound fatigue, and fever of 102°F developed in a 46-year-old man (physician) who cared for case-patients 1 and 2. Within 24 hours, he had tender cervical lymphadenopathy. At hospitalization, he had normal vital signs tender, left-sided lymphadenopathy, and a leukocyte count of 12,000 cells/μL with 26% bands. He was given broad-spectrum, intravenous, antimicrobial drugs. Imaging studies showed major cervical lymphadenopathy. Blood cultures were negative for bacteria, and a throat culture was not obtained. His recovery was slow and protracted. Convalescent-phase serum analyzed by ELISA was positive for GAS-specific antibodies.
Twenty-five days after the onset of illness in case-patient 1, an inflamed papule developed on the right ring finger of a 46-year-old woman who lived with case-patient 2. The papule showed improvement after treatment with oral antimicrobial drugs. Five days later, malaise, runny nose, anorexia, exertional dyspnea, and pain in the proximal region of the left lower leg developed without associated physical findings. Her symptoms worsened over several days. A 10-cm area of ecchymosis on the thigh and major pain on palpation throughout the leg developed that was out of proportion to visual findings. In the emergency department, she had tachypnea, tachycardia, hypotension, and a normal body temperature. Laboratory studies showed acute renal failure and a leukocyte count of 20,000 cells/μL with neutrophilia but no bands. The patient was transferred to a tertiary care facility because of a presumptive diagnosis of necrotizing fasciitis. She had a complicated hospital course that included amputation of the lower left leg and 2 subsequent surgical extensions. Results of histopathologic analysis of the amputated leg were consistent with those for necrotizing fasciitis. The patient survived.
Strains from case-patients 2 and 4 were sent to Houston Methodist Hospital for genome sequencing to a 65-fold depth of coverage by using a MiSeq Personal Sequencer Instrument (Illumina, San Diego, CA, USA). The 2 emm59 case strains differed from each by only a 1-nt deletion. Genome data for the 2 sequenced strains have been deposited in the short-read archive of the National Center for Biotechnology Information (Bethesda, MD, USA) under accession nos. SAMN01991041 and SAMN01991042.
Comparison of the genomes of the strains from Wyoming with hundreds of emm59 genomes (2–4), determined that the case organisms were most closely related to strains that caused a cluster of 6 invasive infections in rural south central Montana in 2010 (2). The emm59 strains from Wyoming and Montana differed from each another by only 15 single-nucleotide polymorphisms, including 1 in the covS gene, which encodes the sensor kinase partner of a key 2-component signal-transduction system (5). Structural changes or inactivation of covR or covS genes can result in up-regulation of up to ≈15% of the GAS transcriptome and increased virulence (6–9).
Because these cases in Wyoming were temporally and geographically clustered and were caused by closely related genetic variants of the unusually virulent emm59 clone, an epidemiologic survey was conducted in an effort to identify a reservoir of the case clone. For the first part of the study, 579 cultures were obtained from in-hospital and out-of-hospital contacts, staff, environmental surfaces, and community throat and wound infections. These cultures were obtained from 168 hospital and clinic employees, 343 hospitalized and ambulatory patients and community contacts of the GAS-infected patients, and 68 hospital and community environmental surfaces. These cultures yielded 39 GAS strains, none of which were emm59.
The second part of the study included a convenience sample of 17 GAS strains obtained from patients with pharyngitis or skin infections in the geographic area in and around the community where the invasive infections occurred. None of these 17 strains were emm59. Many of the emm types commonly causing infections in the United States (10) (www.cdc.gov/abcs/pathogens/pathogen-links.html) were identified in this sample of 56 GAS strains, including emm1, emm2, emm3, emm4, emm12, and emm28. This result is consistent with the striking lack of emm59 strains among strains isolated from patients who had pharyngitis during a large survey in Canada (11).
One of the authors (J.M.M.) suggested that the recent and remarkable change in the epidemiologic and virulence behavior of emm59 GAS strains in Canada and the United States warranted increased attention by public health authorities and infectious diseases practioners (2). We document that an unusually virulent emm59 clone has now emerged to cause severe infections and 1 death in rural northeastern Wyoming. The emm59 strains have recently emerged as the dominant cause of invasive GAS cases in Minnesota (www.cdc.gov/abcs/reports-findings/survreports/gas12.html), which further illustrates the ability of this clone to successfully spread to other geographic areas and cause abundant infections.
One limitation of our study is that we had isolates available from only 2 of the 4 case-patients. However, extensive review of hospital records identified only 1 case of GAS necrotizing fasciitis in the past 5 years, which underscores the otherwise rarity of these episodes in northeastern Wyoming. Thus, we believe we can reasonably hypothesize that all 4 case-patients were infected with clonally related emm59 GAS strains.
Given the speed and modest cost of full-genome sequencing and its role in human health, we remain interested in studying the spread of this clone. Persons responding to clinical situations that might warrant strain genome sequencing should contact the corresponding author.
Dr Brown is director of the hospitalist program and an infectious disease consultant at Memorial Hospital of Sweetwater County, Rock Springs, Wyoming. His research interests are the pathophysiology of sepsis syndromes.
We thank Chandni Valson and Concepcion Cantu for technical assistance; Kathryn Stockbauer for critical reading of the manuscript and editorial assistance; Veronica Taylor, Michlene Mankin, and Lynn Todd for assistance; and Kirtikumar Patel and Tracy Murphy for assistance and guidance.
This study was supported in part by Houston Methodist Hospital System and the Fondren Foundation.
- Tyrrell GJ, Lovgren M, St Jean T, Hoang L, Patrick DM, Horsman G, Epidemic of group A Streptococcus M/emm59 causing invasive disease in Canada. Clin Infect Dis. 2010;51:1290–7.
- Fittipaldi N, Beres SB, Olsen RJ, Kapur V, Shea PR, Watkins ME, Full-genome dissection of an epidemic of severe invasive disease caused by a hypervirulent, recently emerged clone of group A Streptococcus. Am J Pathol. 2012;180:1522–34.
- Fittipaldi N, Olsen RJ, Beres SB, van Beneden C, Musser JM. Genomic analysis of emm59 group A Streptococcus invasive strains, United States. Emerg Infect Dis. 2012;18:650–2.
- Fittipaldi N, Tyrrell GJ, Low DE, Martin I, Lin D, Hari KL, Integrated whole-genome sequencing and temporospatial analysis of a continuing group A Streptococcus epidemic. Emerging Microbes and Infections. 2013;2:e13.
- Levin JC, Wessels MR. Identification of csrR/csrS, a genetic locus that regulates hyaluronic acid capsule synthesis in group A Streptococcus. Mol Microbiol. 1998;30:209–19 .
- Graham MR, Smoot LM, Lux Migliaccio CA, Sturdevant DE, Porcella S, Federle MJ, Streptococcus global virulence network delineated by genome-wide transcript profiling. Proc Natl Acad Sci U S A. 2002;99:13855–60.
- Treviño J, Perez N, Ramirez-Pena E, Liu Z, Shelburne SA III, Musser JM, CovS simultaneously activates and inhibits the CovR-mediated repression of distinct subsets of group A Streptococcus virulence factor-encoding genes. Infect Immun. 2009;77:3141–9.
- Sumby P, Whitney AR, Graviss EA, DeLeo FR, Musser JM. Genome-wide analysis of group A Streptococcus reveals a mutation that modulates global phenotype and disease specificity. PLoS Pathog. 2006;2:e5.
- Horstmann N, Sahasrabhojane B, Suber B, Kumaraswami M, Olsen RJ, Flores AR, Distinct single amino acid replacements in the control of virulence regulator protein differentially impact streptococcal pathogenesis. PLoS Pathog. 2011;7:e1002311.
- Shulman ST, Tanz RR, Dale JB, Beall B, Kabat W, Kabat K, Seven-year surveillance of North American pediatric group A streptococcal pharyngitis isolates. Clin Infect Dis. 2009;49:78–84.
- Shea PR, Ewbank AL, Gonzalez-Lugo JH, Martinez-Gutierrez JC, Rehman HA, Martagon-Rosado AJ, Group A Streptococcus emm gene types among pharyngitis isolates in Ontario, Canada, 2002–2010. Emerg Infect Dis. 2011;17:2010–7 .
Suggested citation for this article: Brown CC, Olsen RJ, Fittipaldi N, Morman ML, Fort PL, Neuwirth R, et al. Spread of virulent group A Streptococcus type emm59 from Montana to Wyoming, USA. Emerg Infect Dis [Internet]. 2014 Apr [date cited]. http://dx.doi.org/10.3201/eid2004.130564
1Current affiliation: Memorial Hospital of Sweetwater County, Rock Springs, Wyoming, USA.
- Page created: February 28, 2014
- Page last updated: February 28, 2014
- Page last reviewed: February 28, 2014
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)